Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc > Say Someth
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(404)
•••
Comment by beenthereon Oct 14, 2011 10:07am
143 Views
Post# 19148875

RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: Say Someth

RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: Say SomethMe no understand.

"There is a written agreement between PMI and Medicago that makes that poison pill harmless"

IF what you are meaning to say is: that PMI and MDG have an agreement that PMI will not make an attempt to take over MDG than thats great.  Please show me where you read that? I think you just made that up now.

EVEN if that was true that does't stop other companies from doing a hostile take over!
We need a poison pill NOW!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities